glp-1 bone loss New Research on GLP-1s & Health ๐ฆด โA new large-scale study has raised questions about the long-term effects of receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary Study reveals exercise and GLP-1
Description
So lets say, for example, from a clinical perspective, if a patient in front of us in clinic, how do we determine where we start

Poletti S, Mazza MG, Benedetti F
The drugs bind to the same GLP-1 receptor in the body that natural GLP-1 binds to, and therefore have the same effects

We monitor patients with existing retinopathy very closely when they begin GLP-1 therapy

This product does not contain GLP-1 or synthetic GLP-1, and is not a GLP-1 agonist drug

Others see more modest results of 5 to 10 percent
